InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
0.00%
)
US TECH 100
19,050.00
(
0.48%
)
Dow Jones
39,411.21
(
0.00%
)
Brent Oil
85.02
(
-0.30%
)
Bitcoin
61,117.35
(
1.43%
)
Post# of 700955
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

GoodGuyBill

Send PM Follow Ignore
Followers 52
Posts 5322
Boards Moderated 0
Alias Born 09/16/2013

GoodGuyBill

Re: jondoeuk post# 243861

Thursday, 09/12/2019 12:40:56 PM

Thursday, September 12, 2019 12:40:56 PM

Post# of 700955
Are any of the two personalised vaccines and four intratumoral-based therapies close to completing a phase3 trial? If not, does it really matter?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

Start posting your company's news
Only $200 per official company press release!